Your browser doesn't support javascript.
loading
Correspondence on 'Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised controlled trial'.
de Wolff, Liseth; Arends, Suzanne; Verstappen, Gwenny M; Vissink, Arjan; Kroese, Frans G M; Bootsma, Hendrika.
Afiliação
  • de Wolff L; Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Arends S; Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Verstappen GM; Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Vissink A; Oral and Maxillofacial Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Kroese FGM; Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Bootsma H; Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands h.bootsma@umcg.nl.
Ann Rheum Dis ; 82(6): e148, 2023 06.
Article em En | MEDLINE | ID: mdl-33757967

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Receptores de Interleucina-6 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Receptores de Interleucina-6 Idioma: En Ano de publicação: 2023 Tipo de documento: Article